These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11014648)

  • 1. Local production of anti-CD4 antibody by transgenic allogeneic grafts affords partial protection.
    Zhan Y; Martin RM; Sutherland RM; Brady JL; Lew AM
    Transplantation; 2000 Sep; 70(6):947-54. PubMed ID: 11014648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival.
    Mottram PL; Murray-Segal LJ; Han W; Zhan Y; Brady JL; Lew AM
    Transpl Immunol; 2000 Nov; 8(3):203-9. PubMed ID: 11147701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts.
    Sutherland RM; Brady JL; Georgiou HM; Thomas HE; Lew AM
    Transplantation; 2000 May; 69(9):1806-12. PubMed ID: 10830215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ; Mottram PL; Mandel TE
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice.
    Akita K; Ogawa M; Mandel TE
    Cell Transplant; 1994; 3(1):61-73. PubMed ID: 7512875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice treated with anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase.
    Niimi M; Takashina M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Kameyama K; Matsumoto K; Hamano K; Esato K
    Transplant Proc; 2000 Nov; 32(7):2086. PubMed ID: 11120078
    [No Abstract]   [Full Text] [Related]  

  • 7. Local secretion of a chimeric anti-CD4 antibody protects against graft rejection in the NOD mouse.
    McKenzie AW; Brady JL; Martin RM; Georgiou HM; Lew AM
    Transplantation; 2000 Apr; 69(8):1745-8. PubMed ID: 10836396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.
    Bumgardner GL; Gao D; Li J; Baskin JH; Heininger M; Orosz CG
    Transplantation; 2000 Dec; 70(12):1771-80. PubMed ID: 11152110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
    Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
    Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell subsets mediating rejection of established fetal pancreas grafts and failure to observe graft adaptation.
    Rees MA; Rosenberg AS; Singer A
    Transplantation; 1990 Jun; 49(6):1130-3. PubMed ID: 2113726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged local expression of anti-CD4 antibody by adenovirally transduced allografts can promote long-term graft survival.
    Londrigan SL; Sutherland RM; Brady JL; Zhan Y; Li R; Estella E; Kay TW; Lew AM
    J Gene Med; 2006 Jan; 8(1):42-52. PubMed ID: 16075436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity.
    Lunsford KE; Gao D; Eiring AM; Wang Y; Frankel WL; Bumgardner GL
    Transplantation; 2004 Oct; 78(8):1125-33. PubMed ID: 15502708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection.
    Mueller R; Davies JD; Krahl T; Sarvetnick N
    J Immunol; 1997 Aug; 159(4):1599-603. PubMed ID: 9257818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The grafted fetal rat pancreas: features of development and rejection.
    Millard PR; Garvey JF; Jeffery EL; Morris PJ
    Am J Pathol; 1980 Jul; 100(1):209-24. PubMed ID: 6772034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Bergese SD; VanBuskirk AM; Ferguson RM; Mullet D; Apseloff G; Gerber N
    Transplantation; 1996 Mar; 61(5):783-91. PubMed ID: 8607184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ protection against islet allograft rejection by CTLA4Ig transduction.
    Londrigan SL; Sutherland RM; Brady JL; Carrington EM; Cowan PJ; d'Apice AJ; O'Connell PJ; Zhan Y; Lew AM
    Transplantation; 2010 Nov; 90(9):951-7. PubMed ID: 20808263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritransplant donor-specific transfusion combined with anti-CD4 and cyclosporine induction therapy prolongs foetal rat pancreas allograft survival.
    Muller CJ; du Toit DF; Page BJ; Muller N; Mattysen J; Lyners R
    Transplant Proc; 2002 Nov; 34(7):2889-90. PubMed ID: 12431646
    [No Abstract]   [Full Text] [Related]  

  • 19. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May; 63(9):1243-51. PubMed ID: 9158016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.